Four horses in Adams County, Colorado, have tested positive for equine infectious anemia (EIA). The index horse was a ...
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Amid rising interest in alternative medicine and growing skepticism of physicians, companies have begun providing a more ...
The first patient has been dosed in the TROPION-Lung17 phase 3 trial evaluating DATROWAY® (datopotamab deruxtecan) compared to docetaxel in patients with TROP2 NMR positive locally advanced or ...
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer ...
Groundbreaking flu transmission study reveals zero infections despite close contact between healthy volunteers and ...
Pfizer remains a Strong Buy, with oncology breakthroughs, a revitalized obesity pipeline, and aggressive cost savings ...
News-Medical.Net on MSN
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
CBeyondTM Phase 2a 26-week extension data update and interim results expected Q1 2026. CBeyond Phase 2a Data Monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results